Eagle LogoPEPTIDE INITIATIVE

Peptide Database

Goals
Fat LossMuscle BuildingInjury HealingAnti-AgingCognitive EnhancementSleep OptimizationImmune SupportGut HealingSkin RejuvenationSexual Health
Peptides
Adipotide
Weight Management
AOD-9604
Weight Management
BPC-157
Healing & Recovery
Cagrilintide
Weight Management
CJC-1295
Growth Hormone
DSIP
Sleep & Recovery
Epithalon
Anti-Aging
GHK-Cu
Anti-Aging
GHRP-2
Growth Hormone
HCG
Hormone Support
Hexarelin
Growth Hormone
HGH
Growth Hormone
IGF-1 LR3
Growth Hormone
Kisspeptin
Hormone Support
Melanotan-2
Cosmetic
MOTS-C
Metabolic
NAD+
Anti-Aging
Oxytocin Acetate
Hormone Support
PEG-MGF
Recovery
PNC-27
Cancer Research
PT-141
Sexual Health
Retatrutide
Weight Management
Selank
Cognitive
Semaglutide
Weight Management
Semax
Cognitive
Sermorelin
Growth Hormone
Snap-8
Cosmetic
SS-31
Mitochondrial
TB-500
Healing & Recovery
Tesamorelin
Growth Hormone
Thymosin Alpha-1
Immune
Tirzepatide
Weight Management
Total Peptides: 32
Back to Home

Peptide Comparison

Tripeptide-29vsAcetyl Hexapeptide-3 (Argireline)

The minimal collagen-mimetic tripeptide (Gly-Pro-Hyp) that stimulates fibroblast collagen synthesis and resists photoaging.

SNARE complex inhibitor that reduces expression wrinkles through topical neuromuscular modulation — the 'Botox in a bottle' peptide.

CosmeticCosmetic

At a Glance

Quick
comparison

Dose Range

Tripeptide-29

0.5%–2% %

Acetyl Hexapeptide-3 (Argireline)

5%–10% %

Frequency

Tripeptide-29

Once daily

Acetyl Hexapeptide-3 (Argireline)

Once daily

Administration

Tripeptide-29

Topical

Acetyl Hexapeptide-3 (Argireline)

Topical

Cycle Length

Tripeptide-29

Ongoing/indefinite

Acetyl Hexapeptide-3 (Argireline)

Ongoing/indefinite

Onset Speed

Tripeptide-29

Moderate (1-2 weeks)

Acetyl Hexapeptide-3 (Argireline)

Moderate (1-2 weeks)

Evidence Level

Tripeptide-29

Limited human trials

Acetyl Hexapeptide-3 (Argireline)

Limited human trials

Efficacy

Benefit
ratings

Tripeptide-29
Acetyl Hexapeptide-3 (Argireline)

Collagen Synthesis

Tripeptide-2988%
Acetyl Hexapeptide-3 (Argireline)0%

Anti-Photoaging

Tripeptide-2983%
Acetyl Hexapeptide-3 (Argireline)0%

Skin Hydration

Tripeptide-2980%
Acetyl Hexapeptide-3 (Argireline)0%

Expression Wrinkle Reduction

Tripeptide-290%
Acetyl Hexapeptide-3 (Argireline)85%

Non-Invasive Treatment

Tripeptide-290%
Acetyl Hexapeptide-3 (Argireline)92%

Safety Profile

Tripeptide-290%
Acetyl Hexapeptide-3 (Argireline)95%

Technical Data

Compound
specifications

Tripeptide-29

Molecular Formula

C12H19N3O5

Molecular Weight

285.3 Da

Half-Life

Oral: rapidly metabolized to Pro-Hyp; accumulates in skin tissue over hours; topical: sustained local activity

Bioavailability

4.4% absolute oral bioavailability; transporter-mediated intestinal absorption; preferential skin tissue accumulation

CAS Number

2239-67-0

Acetyl Hexapeptide-3 (Argireline)

Molecular Formula

C35H62N14O11S

Molecular Weight

887.0 Da

Half-Life

Topical stability dependent on formulation; methionine residue susceptible to oxidation; stable at pH 5.5-7.7

Bioavailability

Limited skin penetration (0.22-0.54%); primarily acts at stratum corneum and superficial epidermis; O/W emulsions enhance delivery

CAS Number

616204-22-9

Applications

Best
suited for

Tripeptide-29

Individuals seeking evidence-based collagen supplementation for skin health

Tripeptide-29 is particularly well-suited for individuals focused on individuals seeking evidence-based collagen supplementation for skin health. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.

Those with photoaged skin from chronic sun exposure

Tripeptide-29 is particularly well-suited for individuals focused on those with photoaged skin from chronic sun exposure. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.

People wanting to support skin hydration and elasticity from both oral and topical routes

Tripeptide-29 is particularly well-suited for individuals focused on people wanting to support skin hydration and elasticity from both oral and topical routes. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.

Users looking for a collagen-mimetic peptide with clinical trial data supporting efficacy

Tripeptide-29 is particularly well-suited for individuals focused on users looking for a collagen-mimetic peptide with clinical trial data supporting efficacy. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.

Acetyl Hexapeptide-3 (Argireline)

Individuals seeking non-invasive reduction of expression lines and dynamic wrinkles

Acetyl Hexapeptide-3 (Argireline) is particularly well-suited for individuals focused on individuals seeking non-invasive reduction of expression lines and dynamic wrinkles. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.

Those with needle phobia who want botulinum toxin-like effects without injections

Acetyl Hexapeptide-3 (Argireline) is particularly well-suited for individuals focused on those with needle phobia who want botulinum toxin-like effects without injections. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.

People targeting crow's feet, forehead lines, and glabellar creases

Acetyl Hexapeptide-3 (Argireline) is particularly well-suited for individuals focused on people targeting crow's feet, forehead lines, and glabellar creases. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.

Individuals looking for preventive anti-wrinkle treatment to slow expression line formation

Acetyl Hexapeptide-3 (Argireline) is particularly well-suited for individuals focused on individuals looking for preventive anti-wrinkle treatment to slow expression line formation. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.

Safety Profile

Side
effects

Tripeptide-29

Common

  • Mild Gastrointestinal Adjustment
  • Aftertaste (oral)
  • Mild Skin Warmth (topical)
  • Initial Skin Purging

Uncommon

  • Allergic Sensitivity

Serious

  • Anaphylaxis (theoretical)
  • Limited Bioavailability and Potential Immunogenicity

Acetyl Hexapeptide-3 (Argireline)

Common

  • Mild Skin Irritation
  • Transient Redness
  • Slight Dryness
  • Stinging on Compromised Skin

Uncommon

  • Contact Dermatitis

Serious

  • Allergic Contact Dermatitis

Research Status

Safety
& evidence

Tripeptide-29

Evidence Level

Limited human trials

FDA Status

Research compound

Safety Overview

Tripeptide-29 (Gly-Pro-Hyp, glycyl-prolyl-hydroxyproline) is a naturally occurring collagen-derived tripeptide with an excellent cosmetic safety profile. This is the fundamental repeat unit of collagen protein, making it highly biocompatible. Both oral and topical forms demonstrate minimal adverse effects in clinical trials. No serious adverse events have been reported in published clinical studies spanning over 15 years. The tripeptide is generally recognized as safe (GRAS) for both topical and oral use by regulatory authorities. Individual responses are generally benign and limited to mild gastrointestinal adjustment with oral supplementation or transient dermal warmth with topical application. The primary safety consideration is allergenicity in individuals with gelatin or collagen allergies, which is rare but requires awareness. Molecular weight (285.3 Da) ensures limited systemic absorption when applied topically.

Contraindications

  • xKnown allergy to collagen, gelatin, or animal-derived protein products
  • xActive skin infections or dermatitis at the topical application site
  • xHypersensitivity to hydroxyproline-containing peptides
  • xConcurrent use with products at extreme pH that may hydrolyze the peptide

Acetyl Hexapeptide-3 (Argireline)

Evidence Level

Limited human trials

FDA Status

Research compound

Safety Overview

Acetyl Hexapeptide-3 demonstrates an excellent safety profile for topical cosmetic use with no serious adverse events reported in clinical studies. At the 10% concentrations used in cosmetic formulations, systemic absorption is minimal and no neurotoxicity has been observed despite its mechanism of action on the neuromuscular junction. The peptide shows a safety margin of approximately 100-fold compared to toxic reference compounds. Primary concerns are limited to local skin irritation in sensitive individuals, such as mild erythema, transient stinging, or contact dermatitis in those with peptide hypersensitivity.

Contraindications

  • xKnown hypersensitivity to acetyl hexapeptide-3 or formulation components
  • xActive skin infections or open wounds at the application site
  • xNo known systemic contraindications at cosmetic concentrations
  • xUse with caution in individuals with neuromuscular disorders (theoretical concern)

Decision Guide

Which is
right for you?

Choose Tripeptide-29 if...

  • Individuals seeking evidence-based collagen supplementation for skin health
  • Those with photoaged skin from chronic sun exposure
  • People wanting to support skin hydration and elasticity from both oral and topical routes
  • Users looking for a collagen-mimetic peptide with clinical trial data supporting efficacy

Choose Acetyl Hexapeptide-3 (Argireline) if...

  • Individuals seeking non-invasive reduction of expression lines and dynamic wrinkles
  • Those with needle phobia who want botulinum toxin-like effects without injections
  • People targeting crow's feet, forehead lines, and glabellar creases
  • Individuals looking for preventive anti-wrinkle treatment to slow expression line formation